Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands

Epidemiology and Infection

Volumn 142, Issue 9, 2014, Pages 1996-1999

  Van Mens, S P ^a,b   Van Deursen, A M M ^b,c   Meijvis, S C A ^a,b   Vlaminckx, B J M ^a   Sanders, E A M ^b   De Melker, H E ^d   Schouls, L M ^d   Van Der Ende, A ^e,f   De Greeff, S C ^d   Rijkers, G T ^a,g  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Linnaeus Institute   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f Netherlands Reference Laboratory for Bacterial Meningitis   (Netherlands)

^g University College Roosevelt   (Netherlands)

Author keywords

Epidemiology; Streptococcus pneumoniae (pneumococcus); vaccination (immunization)

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; AGE; ARTICLE; BACTERIAL COLONIZATION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; PNEUMOCOCCAL INFECTION; SEROTYPE; SEX DIFFERENCE; YOUNG ADULT; GROUPS BY AGE; INFECTION PREVENTION; MIDDLE AGED; STREPTOCOCCUS PNEUMONIAE;

ADULT; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84904652313     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813002860     Document Type: Article

References (18)

1. van Deursen AM, et al. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerging Infectious Diseases 2012; 18: 1729-1737.
2. Miller E, et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infectious Diseases 2011; 11: 760-768.
3. Elston JW, et al. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009. Epidemiology and Infection 2012; 140: 1252-1266.
4. Liesenborghs L, et al. Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010. Vaccine 2013; 31: 1529-1534.
5. Metlay JP, et al. Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Archives of Internal Medicine 2010; 170: 725-731.
6. Pilishvili T, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. Journal of Infectious Diseases 2010; 201: 32-41.
7. Hak E, Shea KM, Jick SS. Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD. Vaccine 2013; 31: 1590-1596.
8. van Gils EJ, et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. Journal of the American Medical Association 2009; 302: 159-167.
9. Flasche S, et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Medicine 2011; 8: e1001017.
10. de Greeff SC, et al. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology (Cambridge, Mass.) 2012; 23: 852-860.
11. Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. Journal of Clinical Microbiology 2003; 41: 4966-4970.
12. Simell B, et al. The fundamental link between pneumococcal carriage and disease. Expert Review of Vaccines 2012; 11: 841-855.
13. Brueggemann AB, et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. Journal of Infectious Diseases 2003; 187: 1424-1432.
14. Harboe ZB, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clinical Infectious Diseases 2010; 50: 329-337.
15. Cobey S, Lipsitch M. Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science (New York, NY) 2012; 335: 1376-1380.
16. Jansen AG, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clinical Infectious Diseases 2009; 49: e23-9.
17. Weinberger DM, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a metaanalysis. Clinical Infectious Diseases 2010; 51: 692-699.
18. Grau I, et al. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonaltype Sweden(1)-ST306. PLoS ONE 2012; 7: e42595.